These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 23204872)
1. Vaginal rings for delivery of HIV microbicides. Malcolm RK; Fetherston SM; McCoy CF; Boyd P; Major I Int J Womens Health; 2012; 4():595-605. PubMed ID: 23204872 [TBL] [Abstract][Full Text] [Related]
2. Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES. McBride JW; Malcolm RK; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Devlin B; Boyd P Int J Pharm; 2019 Jun; 564():207-213. PubMed ID: 30999049 [TBL] [Abstract][Full Text] [Related]
3. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093 [TBL] [Abstract][Full Text] [Related]
4. Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring. McCoy CF; Murphy DJ; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK J Pharm Sci; 2017 Aug; 106(8):2015-2025. PubMed ID: 28456732 [TBL] [Abstract][Full Text] [Related]
6. A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine. Major I; Boyd P; Kilbourne-Brook M; Saxon G; Cohen J; Malcolm RK Contraception; 2013 Jul; 88(1):58-66. PubMed ID: 23177261 [TBL] [Abstract][Full Text] [Related]
7. Silicone elastomer formulations for improved performance of a multipurpose vaginal ring releasing dapivirine and levonorgestrel. Dallal Bashi YH; Murphy DJ; McCoy CF; Boyd P; Brown L; Kihara M; Martin F; McMullen N; Kleinbeck K; Dangi B; Spence P; Hansraj B; Devlin B; Malcolm RK Int J Pharm X; 2021 Dec; 3():100091. PubMed ID: 34977558 [TBL] [Abstract][Full Text] [Related]
8. Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomers. Dallal Bashi YH; McCoy CF; Murphy DJ; Boyd P; Spence P; Kleinbeck K; Devlin B; Malcolm RK Int J Pharm; 2019 Oct; 569():118574. PubMed ID: 31352053 [TBL] [Abstract][Full Text] [Related]
9. Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides. Fetherston SM; Malcolm RK; Woolfson AD Ther Deliv; 2010 Dec; 1(6):785-802. PubMed ID: 22834014 [TBL] [Abstract][Full Text] [Related]
10. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action. Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465 [TBL] [Abstract][Full Text] [Related]
11. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel. Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275 [TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates. Promadej-Lanier N; Smith JM; Srinivasan P; McCoy CF; Butera S; Woolfson AD; Malcolm RK; Otten RA J Med Primatol; 2009 Aug; 38(4):263-71. PubMed ID: 19476564 [TBL] [Abstract][Full Text] [Related]
14. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869 [TBL] [Abstract][Full Text] [Related]
15. Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device. Murphy DJ; Boyd P; McCoy CF; Kumar S; Holt JD; Blanda W; Brimer AN; Malcolm RK J Control Release; 2016 Mar; 226():138-47. PubMed ID: 26878974 [TBL] [Abstract][Full Text] [Related]
16. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. Nel A; Haazen W; Nuttall J; Romano J; Rosenberg Z; van Niekerk N AIDS; 2014 Jun; 28(10):1479-87. PubMed ID: 24901365 [TBL] [Abstract][Full Text] [Related]
17. Use of simulated vaginal and menstrual fluids to model McCoy CF; Spence P; Dallal Bashi YH; Murphy DJ; Boyd P; Dangi B; Derrick T; Devlin B; Kleinbeck K; Malcolm RK Int J Pharm X; 2021 Dec; 3():100081. PubMed ID: 34027386 [TBL] [Abstract][Full Text] [Related]
18. Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES. McBride JW; Boyd P; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Malcolm RK J Control Release; 2019 Mar; 298():1-11. PubMed ID: 30731150 [TBL] [Abstract][Full Text] [Related]
19. Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance. Murphy DJ; Lim D; Armstrong R; McCoy CF; Bashi YHD; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK Drug Deliv Transl Res; 2023 Aug; 13(8):2072-2082. PubMed ID: 34674162 [TBL] [Abstract][Full Text] [Related]
20. Will dapivirine redeem the promises of anti-HIV microbicides? Overview of product design and clinical testing. das Neves J; Martins JP; Sarmento B Adv Drug Deliv Rev; 2016 Aug; 103():20-32. PubMed ID: 26732684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]